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Background: Exercise has consistently yielded short-term, positive effects on health outcomes in people with
multiple sclerosis (MS). However, these effects have not been maintained in the long-term. Behaviour change
interventions aim to promote long-term positive lifestyle change. This study, namely, “Step it Up” will compare the
effect of an exercise plus Social Cognitive Theory (SCT)-based behaviour change intervention with an exercise plus
control education intervention on walking mobility among people with MS.
Methods/design: People with a diagnosis of MS who walk independently, score of 0–3 on the Patient Determined
Disease Steps, who have not experienced an MS relapse or change in their MS medication in the last 12 weeks and
who are physically inactive will be randomised to one of two study conditions. The experimental group will undergo a
10-week exercise plus SCT-based behavioural change intervention. The control group will undergo a 10-week exercise
plus education intervention to control for contact. Participants will be assessed at weeks 1, 12, 24 and 36. The primary
outcome will be walking mobility. Secondary outcomes will include: aerobic capacity, lower extremity muscle strength,
participant adherence to the exercise programme, self-report exercise intensity, self-report enjoyment of exercise,
exercise self-efficacy, outcome expectations for exercise, goal-setting for exercise, perceived benefits and barriers to
exercise, perceptions of social support, physical and psychological impact of MS and fatigue. A qualitative evaluation of
Step it Up will be completed among participants post-intervention.
Discussion: This randomised controlled trial will examine the effectiveness of an exercise plus SCT-based behaviour
change intervention on walking mobility among people with MS. To this end, Step it Up will serve to inform future
directions of research and clinical practice with regard to sustainable exercise interventions for people with MS.
Trial registration: ClinicalTrials.gov, NCT02301442
Keywords: Exercise, Physical activity, Social cognitive theory, Behaviour change, PhysiotherapyBackground
Multiple Sclerosis (MS) is a chronic, often progressive
disease of the central nervous system that results in a
variety of impairments that cause limitations in activities
and participation restrictions. Mobility limitations are
common [1,2] even in the early stages of the disease [3]
and are of significant concern to people with MS [4,5].
Despite recent advances in pharmacological treatments,
exercise therapy remains the cornerstone of the manage-
ment of mobility limitations among people with MS.* Correspondence: susan.coote@ul.ie
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unless otherwise stated.There is an expanding body of evidence suggesting that
exercise has positive effects on many of the impairments
and subsequent activity limitations and restrictions in
participation for people with MS. Systematic reviews
and meta-analyses demonstrate that exercise has a posi-
tive effect on muscle strength [6,7], aerobic capacity [7],
mobility [1], quality of life [8,9] and fatigue [10,11]. One
recent review confirmed the safety of exercise for
people with MS [12]. However, despite increasing evi-
dence for the beneficial effects of physical activity (PA)
and exercise, there is consistent evidence that people
with MS are, in fact, less active than their healthy coun-
terparts [13] and those with other health conditionsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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PwMS in their study met public health guidelines for
mild-to-vigorous PA when compared to 47% of the
healthy controls. This is of concern given that reduced
PA levels are associated with reduced quality of life [16],
and increased risk of cardiovascular disease [17]. Indeed, a
recent population study found that people with MS have a
2.4 fold increased risk of death due to cardiovascular
disease than the general population [18] and this may
be linked with physical inactivity [19].
A recent multi-centre block randomised controlled
trial, which evaluated the effectiveness of community
exercise interventions for people with MS who had min-
imal gait impairment, demonstrated significant benefits
of exercise in the community [20]. Physiotherapist- and
fitness- instructor- led interventions consisted of com-
bined aerobic and strengthening training components.
That exercise intervention resulted in significant im-
provements in the physical impact of MS, psychological
impact of MS, impact of fatigue and walking endurance
[20]. Of note, however, is that these improvements were
not maintained over the longer term and the effect on
the primary outcome measure (walking mobility) was no
longer significant 12 weeks post-treatment [20]. More-
over, there was significant attrition with 50% loss to
follow up at 24 weeks [20]. It is therefore imperative that
future research interventions facilitate long-term adher-
ence and positive changes in PA behaviour, in order to
inform the implementation of sustainable exercise inter-
ventions for people with MS.
A behavioural outcome of paramount importance for
optimised, long-term effectiveness of exercise programmes
is exercise-adherence, particularly post-intervention PA
behaviour [21].
Social Cognitive Theory (SCT) is one of the most
widely-adopted theoretical frameworks for understanding
and optimising PA and other health behaviours. Along
these lines, researchers have developed a programme of
work investigating a SCT-based behaviour change inter-
vention. The intervention involves workshops that aim to
enhance exercise self-efficacy and focus on the provision
of information relative to PA participation based on the
principles of SCT; namely outcome expectations, self-
efficacy, impediments and goal setting. Previous research
has demonstrated that individuals who completed the
SCT-based intervention attended more exercise sessions
than individuals in the standard care group [22]. Subse-
quent research using an online delivery [23] observed sig-
nificant positive effects on PA as measured by the Godin
Leisure Time Exercise Questionnaire that were subse-
quently replicated as a significant, large increase on accel-
erometer step counts [24]. Supplementing the programme
with video coaching further increased PA and this change
was maintained 12 weeks post-intervention [25].Given the positive effects of these two separate but
complementary areas of work it is probable that a com-
bination of exercise and SCT-based behaviour change
approaches could further improve and maintain health
outcomes for people with MS. Step it Up will compare
the effect of an exercise plus SCT-based behaviour
change intervention with an exercise plus control educa-
tion intervention on walking mobility among people
with MS. Our hypothesis is that those in the exercise
and SCT-based intervention will achieve significantly
more improvement in walking mobility than the control
group post-intervention (12 weeks) and that this improve-
ment will be maintained at 24- and 36- week follow up.
Methods/design
Study design
This will be a multi-centre, double blind, randomised,
controlled trial comparing an exercise plus SCT-based
intervention with an exercise plus contact control edu-
cation intervention. Outcomes measures will be admin-
istered at weeks 1, 12, 24 and 36. The study will be
performed in agreement with the Declaration of Helsinki
and is approved by the Health Service Executive Mid-West
Research Ethics Committee, the Galway University
Hospitals Clinical Research Ethics Committee and the
University of Limerick, Faculty of Education and Health
Sciences Research Ethics Committee.
Sample size
It is assumed that the effect of the intervention yields an
average improvement in 6 Minute Walk Test (6MWT)
distance of 36 m with an estimated standard deviation of
48.2 m [26]. In order to have 80% power (at the 5%
significance level) to detect such a difference in mean
improvement in 6MWT over the study period between
groups, a sample of size 62 randomised equally to two
arms (i.e. 31 per arm) is needed. In order to account for
potential drop out a sample of size 72 will be recruited.
Recruitment and eligibility
The participants will be recruited using the social
media, email and postal communications of the MS So-
ciety of Ireland. Additionally people with MS will be re-
cruited via neurology clinics in three urban locations in
the west and south of Ireland. People who are interested
in taking part in the trial will be invited to contact the
research team at the University of Limerick via phone
or email, wherein they will be given an opportunity to
ask questions about Step it Up. When contacted, the re-
searcher will explain the study in detail. Potential par-
ticipants will be screened for selection criteria over the
telephone and participant information leaflet and in-
formed consent forms via post or email will be sent to
each potential participant. Inclusion criteria are: (1)
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18 years or more, (3) Patient Determined Disease Steps
score of 0–3, (4) a sedentary lifestyle (<30 minutes of
moderate to strenuous exercise one day or more per
week over the last six months) and (5) willing to give
written informed consent. Exclusion criteria are: (1)
pregnancy, (2) MS relapse in the last 12 weeks and (3)
changes to MS medication or steroid treatment in the
last 12 weeks.
Random allocation procedures
Participants will be randomly allocated individually to
the exercise plus SCT-based intervention or the exercise
plus contact control education intervention. The alloca-
tion sequence will be concealed from all study personnel
until after data collection is complete. All participants
will be informed that we are evaluating the effect of
combining exercise and education, and as such will be
blind to their group allocation.
Intervention procedures
Exercise plus contact control education intervention
The control group will receive an exercise and a didactic
control education component. The exercise intervention
will be common to both groups, will include aerobic and
strengthening components and will be delivered by
physiotherapists who are trained in the delivery of this
standardised exercise intervention. The aim of the exer-
cise component is to progressively increase the intensity
of both aerobic and strengthening activities to enable
the participants to reach the recently published MS exer-
cise guidelines [7]. The aerobic activity will be walking, the
intensity of which will be monitored using step rate mea-
sured using the Yamax digiwalker pedometer* (which will
be provided to all participants) and an exercise log to
document duration of walking exercise and number of
steps taken. It is widely accepted that 100 steps per minute
equates to three MET or moderate intensity PA among
various clinical populations [27,28]. Similar values have
been established for people with MS where the mean step-
rate threshold at three METs for mean heights was 99 for
people with MS who had minimal walking impairment
and 96 for those with MS who had mild-moderate walking
impairment [29]. Thus the target walking exercise in-
tensity for both groups in the current study will be a
rate of 100 steps per minute. Participants will begin
with 10 minutes of walking twice weekly at a rate of 100
steps/minute and increase incrementally in 5 minute
intervals over 5 weeks until they reach the guideline of
30 minutes twice weekly [7].
The strengthening programme is based on a community-
based exercise programme that has been evaluated pre-
viously [20] and will consist of ten exercises targeting
major muscle groups for the upper and lower extremitiesusing elastic resistance band. The intensity and duration
of the strengthening component of the intervention will
be progressed by increasing the number of repetitions and
sets and changing the resistance of the elastic resistance
band used for each strengthening exercise. Participants
will begin with one set of 10–15 repetitions and gradually
increase the number of sets, repetitions and level of
resistance until they meet the target of two sets of each
exercise twice weekly with sufficient resistance that they
are failing on the 12th repetition. Over the 10-week
programme participants will attend the group exercise
class on six occasions, supplemented with a telephone
coaching call in the weeks without classes (intervention
weeks 4, 6, 7 and 9). These telephone calls will consist
of direct questions about the frequency, intensity, type
and duration of exercise they have completed and
whether they have experienced any adverse events or
relapses. Of note, these telephone calls will also be
conducted at weeks 16, 20 and 36, after the 10-week
intervention has been completed. After each of the
group exercise classes the control group will receive an
education session about topics unrelated to PA behaviour,
e.g. diet, vitamin D, sleep, temperature and hydration, and
immunisations and vaccinations.
Exercise plus SCT-based intervention
The exercise plus SCT-based intervention group will re-
ceive the same exercise intervention as the control
group (as described in the previous section).This group
will also receive a behaviour change intervention based
on the principles of SCT. The SCT-based education
sessions will be delivered after each exercise session by
physiotherapists who are trained in this area and will
incorporate the principle elements of SCT including
self-efficacy, outcome expectations, impediments and
goal-setting. Session 1 will consist of a discussion on the
benefits of exercise for persons with MS, instructions
for beginning an exercise program, education on out-
come expectations (physical, social, self-evaluative and
mental outcome expectations) of the Step it Up inter-
vention and instructions on effective self-monitoring of
one’s behaviour (use of exercise logs and pedometers).
Session 2 will include group discussion and physiotherapy-
led guidance on setting specific, measureable, adjustable,
action-oriented, realistic and time-based exercise and
PA goals. Participants will also complete group-based
written assignments and document their exercise goals
during this session. Session 3 will focus on the concept
of self-efficacy, with emphasis on the sources of
self-efficacy, namely: mastery accomplishments, social
modelling, social persuasion and the interpretation of
physiological states. Session 4 will consist of discussion
and documentation of the barriers and facilitators of
exercise (environmental, social, health and cognitive
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long-term maintenance of a physically-active lifestyle.
The last education session will involve a celebratory
ceremony for the participants to commend them on their
successful completion of the Step it Up programme.
Beyond providing presentation notes, individual reflection
and written exercises, group discussion on each of the
principles of SCT, and providing on-going feedback on all
aspects of PA behaviour, the program will include video
files of people with MS discussing PA behaviour and their
experiences of initiating and maintaining a physically-
active lifestyle. The use of video files of people with MS is
grounded in a central tenet of SCT- the promotion of
self-efficacy via social modelling and social persuasion. On
the weeks when the participants do not attend group
sessions, they will receive a telephone coaching call from
the physiotherapist. These coaching calls will consist
of guided conversations that consider the components
of SCT delivered in the previous session and a revision
of other components. Of note, participants will also
receive telephone coaching calls from the physiotherapists
at weeks 16, 20 and 36 (after the 10-week programme has
been completed) in order to revise the topics covered
during the Step it Up programme and to act as a support
for long-term maintenance of a physically-active lifestyle.
Ensuring the fidelity of the interventions
A manual of operating procedures will be provided to
the physiotherapists and incorporated into training for
the physiotherapists and provided to them for their use
throughout their delivery of the Step it Up programme.
The physiotherapists’ adherence to the Step it Up inter-
vention protocol will be verified using ad-hoc video
analysis of the intervention programme. Fidelity of the
intervention dose will be further monitored by recording
participant attendance for each session and participant
exercise completion and intensity of exercise using ex-
ercise log books throughout the 10-week intervention.
Measures
Outcome measures will be conducted pre-intervention
(week 1), post-intervention (week 12), and at 3-months
(week 24) and 6- months (week 36) follow-up. The out-
come measures for this study include those measures
recommended by an expert consensus group on a core
set of outcome measures for exercise trials in MS [30]
and demonstrate acceptable reliability and validity coeffi-
cients among people with MS. The participants will be
sent all of the self-report outcome measures via post to
complete prior to their objective assessment meeting
with the blinded assessor (SH). Participants will receive
instruction on how to complete each self-report measure
according to standardised instructions for each measure
of outcome. The postdoctoral researcher (SH) will beblind to allocation and will conduct all objective assess-
ments on the week preceding the start of the Step it Up
intervention.
Screening measure
Potential participants will be screened for eligibility for
this study using the PDDS scale [31]. The PDDS scale
contains a single item for measuring self-reported neuro-
logical impairment on an ordinal level from zero (Normal)
to eight (Bedridden). Scores from the PDDS are linearly
and strongly related with physician-administered Ex-
panded Disability Status Scale (EDSS) scores [31].
Demographic and clinical information
Participants will be asked to supply details regarding age,
gender, level of formal education, time since diagnosis of
MS, duration of symptoms of MS, falls history, exercise
history, marital status and employment status. Addition-
ally, a researcher formally training in the use of the
Expanded Disability Status Scale (EDSS) (SH) will
administer the EDSS to all participants at baseline in
order to gain a descriptive variable of disability. The
EDSS is a clinical outcome measure of MS disease pro-
gression and is commonly the standard that other out-
come measures are compared against [32]. It consists
of functional systems subscales and a total score which
is an ordinal rating ranging from 0 (normal neuro-
logical status) to 10 (death due to MS).
Primary outcome
Consistent with the finding that people with MS report
mobility limitations as their greatest concern [5], the
primary outcome will be walking mobility. This will be
measured by the Six Minute Walk Test (6MWT), Timed
Up and Go test (TUG) and the Multiple Sclerosis Walking
Scale-12 (MSWS-12) in order to capture walking endur-
ance, walking speed and participant-reported limitations
in walking.
The 6MWT will involve the participants being
instructed to walk for six minutes as quickly and safely
as possible [33] and the distance (m) covered will be
recorded. The 6MWT has demonstrated excellent test-
retest reliability and concurrent validity among people
with mild to moderate MS [33].
For the TUG, the participants will be instructed to
stand up from a chair, walk 3 m, then turn around walk
back to the chair and sit down, as quickly and safely as
possible. The participants’ performance will be timed
and the mean score of three performances of the TUG
will be used in analysis. TUG-cognitive involves adding
a cognitive task (subtracting three from a random num-
ber between 20 and 100) while performing the TUG.
Previous research demonstrates excellent test-retest reli-
ability for people with mild MS (EDSS: 0–4) [34].
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self-reported walking limitations due to MS during the
previous two weeks. All items are measured on a likert
scale ranging from 1 (not at all) to 5 (extremely). Psycho-
metric testing of the MSWS-12 has demonstrated that it
has excellent internal consistency [35,36], test-retest
reliability [37] and concurrent validity [38].
Secondary outcomes
The 5 times sit to stand test [39] will be used to measure
lower extremity muscle strength. The participants will be
instructed to stand up and sit down as quickly as possible
when rising from a chair. It has demonstrated excellent
construct validity among people with MS [33]. The 5
times sit to stand test has also demonstrated moderate to
excellent concurrent validity among people with MS who
had mild to moderate disability [40].
Aerobic capacity will be measured among participants
using the Modified Canadian Aerobic Fitness Test [41]
(mCAFT). The mCAFT is a graded step test and can
predict VO2peak using a published regression equation
for people with MS [42].
The Hospital Anxiety and Depression Scale (HADS)
[43] is a 14-item self-report scale and will be used to
measure anxiety and depression among participants. The
HADS has been validated among people with MS, dem-
onstrating acceptable sensitivity (90% and 89% for the
depression subscale) and specificity (87% and 81% for
the anxiety subscale) [44].
The Symbol Digit Modalities Test (SDMT) [45] will be
used to measure processing speed. Participants will be pre-
sented with a series of nine geometric symbols, each paired
with a different single digit number in a key at the top of
the page. Participants will be instructed to provide the digit
associated with each corresponding symbol and the score
shall be the number correctly completed in 90 seconds.
The SDMT is a commonly-used, validated assessment of
cognitive function in individuals with MS [46].
PA will be measured using the Godin Leisure-Time
Exercise Questionnaire (GLTEQ) [47] and the short-
form of the International Physical Activity Questionnaire
(IPAQ) [48]. Evidence for the validity of these measures
in people with MS has been reported [49-51]. The
GLTEQ is a self-administered assessment that has three
items that measure the frequency of strenuous, moderate,
and mild physical activities for periods of more than
15 min during a person’s free time over the previous
week. The short-form of the IPAQ was designed for
population surveillance of PA among adults and mea-
sures the frequency and duration of vigorous-intensity
activities, moderate-intensity activities, walking and
sitting during a 7-day period.
Additionally, the SenseWear Arm band (SWA) will be
used as an objective estimate of PA using both meandaily step count and mean daily energy expenditure esti-
mates over a 7-day period. The acceptable criterion val-
idity of the mean daily energy expenditure (kilocalorie
estimates) over a 7-day period of the SWA has been dem-
onstrated among people with mild disability with MS [52].
Adherence to the exercise programme will be docu-
mented throughout the 10-week intervention via self-
report exercise logs. These exercise logs will capture
information regarding participant attendance at the
exercise classes. In relation to the strengthening compo-
nent of the exercise programme, the number of sets,
repetitions and colour of resistance band used will be
recorded for each exercise during each exercise session.
Additionally, the duration of each walking exercise
session and pedometer-measured step count will be
recorded in the exercise logs. The logs will also record
participants’ reported enjoyment of each exercise
session using a likert scale ranging from one (not at all) to
seven (very much) and their perceived rate of exertion
during each exercise session using a likert scale ranging
from 6 (no exertion at all) to 20 (maximal exertion) [53].
Five questionnaires will be implemented to measure
SCT domains. These include the Exercise Self-Efficacy
Scale (EXSE), Exercise Goal Setting (EGS) scale [54],
Multidimensional Outcomes Expectations for Exercise
Scale (MOEES) [55], the Social Provisions Scale (SPS)
[56] and an exercise benefits and barriers questionnaire.
These questionnaires have been validated and have been
used in previous research on PA [23,57,58].
The Multiple Sclerosis Impact Scale 29 (MSIS-29) [59]
is a measure of the physical and psychological impact of
MS from the patient’s perspective. Excellent internal
consistency for the physical and psychological subscales,
respectively, and moderate to excellent concurrent validity
for the physical and psychological subscales, respectively
have been reported for the MSIS-29 [60].
The Modified Fatigue Impact Scale (MFIS) is a 21-item
self-report questionnaire and will measure the impact of
fatigue on physical, cognitive and psychosocial aspects
functioning among participants. Excellent test-retest
reliability [61], internal consistency [62] and concurrent
validity [61] has been reported in MS populations.
Statistical analysis
Suitable numerical statistics and graphical summaries
will be used to describe characteristics of the sample at
baseline and to assess the validity of any distributional
assumptions needed for the formal analysis. The flow of
trial participants and the level of missing data for all out-
comes will be documented and an analysis into the
cause of missingness (if present) will be conducted. All
losses to follow-up and dropouts will be accounted, and
where possible, reasons documented. The primary ana-
lysis will compare differences in the primary response
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the two treatment arms across the 12 week time period.
Several analyses will be performed to compare the
change in the primary response variable across time and
between groups while adjusting for baseline as appropriate.
These will include linear mixed models for a continuous
response with different covariance structures compared in
order to best model the correlation structure within sub-
jects across time. All tests of significance will be two-sided
and conducted at an alpha = 0.05 level of statistical signifi-
cance. A further analysis will be performed to compare the
estimated effect of the intervention when imputing values
for all missing data in order to investigate the assumptions
relating to missingness, and the effect, if any, on the overall
conclusion. Multiple imputation will be performed
using a Predictive Model Based Method using chained
equations where each missing value is replaced by 20
imputed values. The results of each ‘complete’ model (i.e.
with imputed values) will be averaged using the Barnard-
Rubin adjustment method.
Qualitative analysis
Qualitative study of participants’ experiences of the Step it
Up programme will be completed at weeks 12 and 36.
This study is to compliment the quantitative findings and
aspects and is response to a recent call for researchers
to include a qualitative component to intervention trials
[63]. In brief, 24 participants who complete the Step it Up
programme will take part in one to one semi-structured
interviews with questioning focusing on what worked and
did not work; interviews will be audio-recorded, tran-
scribed and analysed using thematic analysis using a quali-
tative descriptive design [64,65]. The pertinent features
underlying qualitative description are: purposive sampling;
a semi-structured interview schedule with open-ended
questions; content data analysis and; descriptive results,
close to the dataset [64,65].
Discussion
This RCT will examine the effectiveness of an exercise plus
SCT-based behaviour change intervention on walking mo-
bility among people with MS. The Step it Up programme
addresses limitations of exercise trials in the MS population
highlighted in the literature to date. Step it Up will combine
the well-recognised behaviour change principles of SCT
with an evidence-based exercise programme, employing
a mixed-methods approach and a long-term follow-up
period. In order to systematically examine the intervention
effects on walking mobility the Step it Up programme will
include an array of outcome measures that will be used as
manipulation checks, i.e. lower extremity muscle strength,
aerobic capacity, SCT domains. Additionally, the exercise
component of the Step it Up programme will be informed
by published evidence-informed PA guidelines for peoplewith MS [7]. The Step it Up programme will build on the
work of Coote and colleagues [20,66] and Motl and col-
leagues [25] by evaluating the combined effects of an
evidence-based exercise programme with a behavioural
change programme using a RCT design. To this end, Step
it Up will serve to inform future directions of research and
clinical practice with regard to sustainable exercise inter-
ventions for people with MS.
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